GS ORI-GO
LIVE

Serial Number

79457737

Owner

Lonza Ltd.

Filing Date

Jun 18, 2026

Add to watchlist:

No watchlists yet
View on USPTO

GS ORI-GO Trademark

Serial Number: 79457737

GS ORI-GO is a trademark filed by Lonza Ltd. on June 18, 2026. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

Lonza Ltd. (7 trademarks)

Lonzastrasse
Visp 3930 , CH

Entity Type: 03

Trademark Details

Filing Date

June 18, 2026

Registration Date

Not Registered

Goods & Services

Biological preparations, for medical use, namely, genetically modified cells and genetically modified vectors for production of human, animal and synthetic proteins for medical purposes and, for clinical and commercial use in human and animal therapies; Gene therapy products, namely, modified cells and modified cell platforms.

Scientific and medical research in the field of biotechnology; Technical consultancy and project planning in the field of biological research relating to proteins; research and development in the field of proteins for others; scientific research and laboratory services in the fields of editing, modification, engineering and regulation of genes, genome and cells for the development of pharmaceutical and biological preparations for human and veterinary use; aggregating, analyzing and providing data in the field of genomics; custom design and development of cell lines designed for others for scientific research, drug discovery and development; scientific research and laboratory services in the fields of editing, modification, engineering and regulation of genes, genome and cells for the development of medical diagnostic products.

Cells for scientific, laboratory, medical research and clinical use including genetic material for protein production; biological preparations, not for medical use, namely, genetically modified cells and vectors for production of human, animal and synthetic proteins, for clinical and commercial use in scientific research, and for use in pharmaceutical research; kits consisting of cell lines, reagents, enzyme substrates and/or genetically modified chemical preparations; reagents, nucleic acids and nucleotides for scientific use and for research purposes in the field of clinical research, drug development, research in agriculture and genetics; reagent kits consisting of reagents and chemical preparations; samples of nucleotide sequence variants and modifications for use in the field of scientific research, clinical research and scientific research in diagnosis.

Filing History

APPLICATION FILING RECEIPT MAILED
Sep 10, 2026 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 10, 2026 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Sep 10, 2026 REPR